Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaike Chemical Group Regulatory News (HAIK)

  • There is currently no data for HAIK

Trading Statement

13 Dec 2013 08:55

RNS Number : 4859V
HaiKe Chemical Group Ltd.
13 December 2013
 

HaiKe Chemical Group Ltd

 

Trading Update

 

HaiKe Chemical Group Limited ("HaiKe" or the "Company" or the "Group") (AIM: HAIK), the AIM quoted petrochemical, speciality chemical and biochemical business based in China, today provides an update on trading ahead of its final results for the twelve month period ended 31 December 2013.

 

The refining business remained volatile throughout H2 with the demand for gasoline recovering in Q3 but then falling in Q4. A contributing factor for this mixed second half was due to the government action regarding environmental concerns about the haze emitted from automobile exhausts. Conversely, the market for diesel picked up slowly in Q4 on the back of rising demand from both industrial and heating use.

 

The relaxation of the pricing mechanism has had an immaterial impact on the refineries, and overall the move towards a freer operating environment remains encouraging. The Company has adapted operating strategies in order to compensate for the volume shortfall and improve overall margins, for example making continued improvement to the product mix in order to focus on the more profitable high-end products, through the development of niche products for specific areas and by increasing trading activity which has low but stable margins.

 

The speciality chemicals business remained profitable in H2. Specifically, High-tech Spring has overcome the difficulties of volume decrease and margin squeeze and made a modest profit in H2. Hebang generated a small profit in Q4 but this was not sufficient to cover the prior losses. The Group has taken certain actions to adapt to the changing environment and further develop the speciality chemical division. These include making best use of its existing resources by, for example, increasing exposure to trading and implementing more efficient tax planning.

 

There was no significant change to the biochemicals business which made comparative earnings in H2.

 

On the financial side, the Group recorded a total turnover of CNY36.8 billion for the first 11 months of 2013, up 140% year-on-year. Accumulated net loss after tax for the period was CNY359.8 million, compared to a loss of CNY186.9 million for the same period in 2012. Net borrowings (short/long term borrowing minus bank deposit) amounted CNY7.4 billion at end-Nov, compared to CNY6.2 billion at beginning of the year.

 

Against this background the Group continues to explore its restructuring options in order to try to realise value for all stakeholders. 

 

Mr Xiaohong Yang, Executive Chairman, said:

 

"We are disappointed by the performance especially in the refinery division. Given the difficult operating environment, we've carried out several measures to compensate for the shortfall in the refinery as well as further development of speciality chemicals. Meanwhile, the Company continues to examine various options for the best interest of our shareholders."

 

For further information please contact:

 

HaiKe Chemical Group

George Zeng, Chief Financial Officer

george@haikechemical.com

+86 138 2520 2570

Westhouse Securities

Martin Davison

 

+44 (0) 20 7601 6100

Cardew Group

Shan Shan Willenbrock

Tom Horsman

haike@cardewgroup.com 

+44 (0) 20 7930 0777

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMMMZRFGGFZG
Date   Source Headline
20th Apr 20099:13 amRNSRe Joint Venture
1st Apr 20097:00 amRNSChange of Adviser
16th Mar 20097:00 amRNSAppointment of Chief Financial Officer
12th Nov 20081:39 pmRNSTrading Statement Replacement
11th Nov 20088:44 amRNSTrading Statement
26th Sep 20087:00 amRNSProduction Update
17th Sep 20087:00 amRNSInterim Results
8th Sep 20088:45 amRNSMajor Contract & Project Comm
8th Sep 20087:00 amRNSNotice of Results
4th Sep 20087:00 amRNSCompany Update
23rd Jul 20082:01 pmRNSTrading Statement
11th Jul 200812:57 pmRNSDirector/PDMR Shareholding
11th Jul 200812:54 pmRNSDirector/PDMR Shareholding
10th Jul 20087:00 amRNSSpeciality chemical facility
20th Jun 200811:23 amRNSTrading Statement
20th Jun 20087:14 amRNSResult of AGM
20th Jun 20087:00 amRNS1st Quarter Results
11th Jun 20082:41 pmRNSNotice of Results
23rd May 200812:34 pmRNSAnnual Report and Accounts
30th Apr 20087:01 amRNSHolding(s) in Company
7th Apr 20087:01 amRNSFinal Results
1st Apr 20087:00 amRNSNotice of Results
31st Mar 20089:27 amRNSStmnt re Share Price Movement
17th Dec 20074:38 pmRNSDirector/PDMR Shareholding
17th Dec 20079:38 amRNSDirector/PDMR Shareholding
12th Dec 200711:15 amRNSTrading Update
19th Nov 20077:00 amRNS3rd Quarter Results
2nd Nov 200710:24 amRNSTrading Statement
9th Oct 20071:00 pmRNSDirector/PDMR Shareholding
27th Sep 20072:24 pmRNSDirector/PDMR Shareholding
21st Sep 20079:43 amRNSTrading Statement
18th Sep 20079:00 amRNSTransfer of minority stake
10th Sep 20077:01 amRNSInterim Results
24th Aug 20071:53 pmRNSHolding(s) in Company
17th Aug 200711:24 amRNSAIM Rule 26
15th Aug 20071:33 pmRNSNotice of Results
20th Jun 200710:11 amRNSAGM Statement
1st Jun 200712:34 pmRNSDirector/PDMR Shareholding
30th May 20075:04 pmRNSDirector/PDMR Shareholding
24th May 20077:00 amRNS1st Quarter Results
22nd May 20077:01 amRNSShareholder Documentation
17th May 20078:43 amRNSNotice of Results
3rd Apr 20079:13 amRNSDirector/PDMR Shareholding
3rd Apr 20077:01 amRNSFinal Results
27th Mar 20073:12 pmRNSNotice of Results
15th Feb 20075:03 pmRNSHolding(s) in Company
14th Feb 20078:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.